CSIMarket
 
Tactile Systems Technology Inc   (NASDAQ: TCMD)
Other Ticker:  
 
 
Price: $14.5800 $0.23 1.603%
Day's High: $14.58 Week Perf: 10.37 %
Day's Low: $ 14.19 30 Day Perf: 8.08 %
Volume (M): 120 52 Wk High: $ 21.10
Volume (M$): $ 1,742 52 Wk Avg: $14.37
Open: $14.19 52 Wk Low: $11.12



 Market Capitalization (Millions $) 353
 Shares Outstanding (Millions) 24
 Employees 992
 Revenues (TTM) (Millions $) 293
 Net Income (TTM) (Millions $) 17
 Cash Flow (TTM) (Millions $) 33
 Capital Exp. (TTM) (Millions $) 3

Tactile Systems Technology Inc
Tactile Systems Technology Inc. is a publicly traded medical device company focused on developing and marketing at-home therapy devices that improve circulation and reduce swelling, discomfort and pain for individuals with lymphedema, chronic venous insufficiency, and other conditions affecting the lymphatic and vascular systems.

Headquartered in Minneapolis, Minnesota, the company was founded in 1995 by a licensed physical therapist, and to date, it has continued to develop clinically proven, non-invasive, and cost-effective products that aid in the management of chronic diseases. Tactile Systems Technology primarily markets its products through direct sales and a network of distributors across the United States as well as partnering with healthcare professionals such as lymphedema and wound care therapists.

One of their primary products, the Flexitouche system, utilizes a pneumatic compression technology to simulate the hand motion of a lymphatic therapist or clinician performing various stages of manual lymph drainage. It is indicated for the treatment of lymphedema in the arms, legs or trunk, and has been clinically demonstrated to reduce swelling, increase limb mobility and reduce the risk of infection. Another product, the Entr' System, is a simplified and portable version of the Flexitouche system, and is intended for use by patients and caregivers in the home environment.

Tactile Systems Technology has a strong commitment to research and development, and as a result, the company has obtained multiple patents for its innovative technology. The company also collaborates with leading healthcare professionals and institutions to conduct research studies aimed at improving the quality of life for patients with chronic diseases.

In addition, Tactile Systems Technology has received numerous accolades and recognitions for its outstanding contribution to the medical device industry. These include being named Forbes' "Top 100 Public Companies in America" and "Top Small Cap Growth Companies" along with various industry awards, such as the "2017 Global Frost & Sullivan Award for Growth Excellence Leadership" in the compression therapy industry.

Overall, Tactile Systems Technology's mission is to improve the lives of individuals living with chronic diseases based on its strong belief in the power of science, innovation and committed partnership with patients, healthcare professionals and the community.


   Company Address: 3701 Wayzata Blvd, Suite 300 Minneapolis 55416 MN
   Company Phone Number: 355-5100   Stock Exchange / Ticker: NASDAQ TCMD


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
BDX        4.29% 
BSX        8.91% 
INSP        8.91% 
MDT        2.89% 
MMM        9.11% 
SYK        7.46% 
• View Complete Report
   



Management Changes

Tactile Medicals Bold Moves: New Board Appointment and Cutting-Edge Lymphedema Technology Signal Strategic Growth in Chronic Care Management,

Published Mon, Jan 13 2025 1:00 PM UTC

Tactile Medical s Strategic Moves: A New Board Member and Innovative Therapies Signal Growth Amid Rising Demand for Chronic Care SolutionsBy CSI Market Reporter MINNEAPOLIS, MN ? On January 13, 2025, Tactile Systems Technology, Inc. (Nasdaq: TCMD), a rapidly evolving player in the medical technology sector, announced the appointment of Laura King to its Board of Direc...

Product Service News

In a significant breakthrough in the treatment of lymphedema, Tactile Medical has announced the launch of i...

Published Wed, Oct 2 2024 12:00 PM UTC

Innovative Technology to Address Upper Extremity Lymphedema: Tactile Medical Unveils Next-Generation Nimbl Platform In a significant breakthrough in the treatment of lymphedema, Tactile Medical has announced the launch of its next-generation Nimbl platform. This state-of-the-art technology is set to transform the care provided to patients suffering from upper extremity lymph...

Clinical Study

Advanced Pneumatic Compression Therapy Yields Positive Results for Lymphedema Patients in Largest U.S. Clinical Trial

Published Wed, Sep 25 2024 12:01 PM UTC

Summary : Tactile Medical s Flexitouch System demonstrates significant improvements and high compliance in lymphedema treatment.Tactile Medical has announced groundbreaking results from the largest U.S. prospective clinical trial ever conducted on the treatment of lymphedema using advanced pneumatic compression device therapy. The trial, which evaluated the efficacy of the F...

Tactile Systems Technology Inc

Tactile Systems Technology Inc: Defying Industry Odds with Astounding Financial Resilience

Tactile Systems Technology Inc: A Beacon of Growth Amid Industry Challenges
In an era where many companies in the Medical Equipment & Supplies sector are grappling with obstacles, Tactile Systems Technology Inc (Nasdaq: TCMD) has emerged as a beacon of resilience and growth. The recent financial results for the second quarter of 2024 showcase a robust performance that not only defies the industry trend but also highlights the company's strong fundamentals and future potential.
Impressive Financial Rebound
For the most recent fiscal period, Tactile Systems Technology reported an earnings per share (EPS) of $0.18, a substantial increase from the same quarter last year when the EPS stood at $0.00. Moreover, this marks a remarkable turnaround from the loss of $-0.09 per share recorded in the prior financial reporting period. The company?s ability to achieve positive EPS amidst a challenging economic environment underscores its effective management strategies and operational efficiency.

Tactile Systems Technology Inc

Tactile Systems Technology Inc Reports 5.046% Rise in Revenue for Q4 2023 Period



Tactile Systems Technology Inc, a prominent Medical Equipment & Supplies company, recently released its financial results for the October to December 31, 2023 period. The company reported improved profit margins and a significant increase in net earnings. However, while revenue grew compared to the previous reporting period, it fell short when compared to the industry average. This article aims to analyze the financial highlights while providing a contextual evaluation of Tactile Systems Technology Inc's performance.
Financial Analysis:
1. Earnings per Share (EPS): Tactile Systems Technology Inc's profit per share for Q4 2023 increased by 30.65% to $0.29 from $0.22 per share in the previous year. However, EPS dropped by -68.76% to $0.94 per share compared to the prior reporting period.







Tactile Systems Technology Inc's Segments

  Tactile Systems Technology Inc Outlook

On February 20 2024 the Tactile Systems Technology Inc provided following guidance

On February 20, 2024, Tactile Systems Technology, Inc. reported their financial results for the fourth quarter and full year of 2023. The company saw a significant increase in their full year revenue, with an 11% growth compared to the previous year. Additionally, their full year net income surged by 260%, showcasing the company's strong financial performance. The adjusted EBITDA also saw a notable increase of 62% for the full year.

The company also introduced their outlook for the full year of 2024, indicating a positive trajectory for their financial performance. With the impressive growth seen in 2023, Tactile Systems Technology, Inc. is poised to continue their success and potentially achieve even...





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com